Who is VANFLYTA for?

VANFLYTA is a prescription medication to help you with a specific type of leukemia called AML.

VANFLYTA is FDA-approved in combination with certain chemotherapy medicines and alone as maintenance therapy to treat adults who have newly diagnosed AML with a FLT3-ITD mutation.

Your healthcare provider will perform a test to make sure that VANFLYTA is right for you.

VANFLYTA is not for use alone as maintenance therapy after a hematopoietic stem cell transplant.

It is not known if VANFLYTA is safe and effective in children.

Learn more about VANFLYTA
with this patient brochure

Support program icon

Support programs are available to help you or your loved one access VANFLYTA.

HCP website icon

If you are a healthcare professional, please visit our site.